Adding CT-179 to combinations of treatments may bring new efficacy to brain tumor therapy." The research teams collaborated ...

Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice. The novel drug CT-179 was ...

Children struck down with brain cancer have been given new hope with Queensland scientists hailing a breakthrough in the ...

Childhood brain cancer research breakthrough could transform treatment: International study: Atlanta, Georgia Thursday, February 6, 2025, 14:00 Hrs [IST] Brain cancer is the secon ...

The research teams collaborated with U.S. drug company, Curtana Pharmaceuticals, that developed the experimental small molecule drug, termed CT-179. They found that the drug effectively targets ...

Timothy Gershon, Emory University Professor The research teams collaborated with U.S. drug company, Curtana Pharmaceuticals, that developed the experimental small molecule drug, termed CT-179.

A new study reveals that the experimental drug CT-179 targets OLIG2-positive cancer stem cells, preventing tumor recurrence in medulloblastoma. Preclinical trials show the drug crosses the blood-brain ...

The research teams collaborated with US biopharmaceutical company, Curtana Pharmaceuticals, which has developed an experimental drug, CT-179. The researchers found that the drug effectively ...